Intellia Therapeutics NTLA Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Intellia Therapeutics's net margin?
- Intellia Therapeutics (NTLA) reported net margin of -597% in Q1 2026.
- How has Intellia Therapeutics's net margin changed year-over-year?
- Intellia Therapeutics's net margin increased by 48.3% year-over-year, from -1,154.1% to -597%.
- What is the long-term trend for Intellia Therapeutics's net margin?
- Over 5 years (2020 to 2025), Intellia Therapeutics's net margin has grown at a 21.4% compound annual growth rate (CAGR), from -231.5% to -609.9%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.